Effectiveness and cost-utility of telemonitoring lab results and e-consultations in rheumatoïd artritis.

Effectiveness and cost-utility of telemonitoring lab results and e-consultations in rheumatoïd artritis. - Joint Monitoring

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON52237

Enrollment

142

Registered

2022-04-22

Start date

2022-01-01

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoïd arthritis

Interventions

Applying the use of lancets at home for the (tele)monitoring of the essential laboratory results and the e-consultation is the intervention. The intervention is the shift from blood sampling and con

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Diagnosis of rheumatoid arthritis as stated by the rheumatologist; - Reported Patient Reported Outcomes Measures; - Minimum age of 18 years; - Able to provide informed consent; - Literacy in Dutch.

Exclusion criteria

Exclusion criteria: - Arthritis other than rheumatoid arthritis; - Unable to take blood samples via lancets.

Design outcomes

Primary

Measure	Time frame
The main study parameters are the effects measured in Patient Reported Outcomes, making use of the EQ-5D questionnaires and the societal costs associated with the implementation of telemonitoring amongst RA patients.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)